These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26830918)

  • 1. The effect of the duration of intravenous zolendronate medication on the success of non-surgical endodontic therapy: a retrospective study.
    Dereci Ö; Orhan EO; Irmak Ö; Ay S
    BMC Oral Health; 2016 Feb; 16():9. PubMed ID: 26830918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.
    Hsiao A; Glickman G; He J
    J Endod; 2009 Nov; 35(11):1525-8. PubMed ID: 19840641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta].
    Yamashita S
    Clin Calcium; 2010 Jun; 20(6):918-24. PubMed ID: 20513950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
    Gómez-Moreno G; Arribas-Fernández MC; Fernández-Guerrero M; Boquete-Castro A; Aguilar-Salvatierra A; Guardia J; Botticelli D; Calvo-Guirado JL
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1391-7. PubMed ID: 24867519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
    De Cock E; Hutton J; Canney P; Body JJ; Barrett-Lee P; Neary MP; Lewis G
    Clin Ther; 2005 Aug; 27(8):1295-310. PubMed ID: 16199254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcome of endodontic microsurgery that uses EndoSequence BC root repair material as the root-end filling material.
    Shinbori N; Grama AM; Patel Y; Woodmansey K; He J
    J Endod; 2015 May; 41(5):607-12. PubMed ID: 25702859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.
    Craig SJ; Youssef PP; Vaile JH; Sullivan L; Bleasel JF
    Intern Med J; 2011 Feb; 41(2):186-90. PubMed ID: 20214696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report.
    Scoletta M; Arduino PG; Pol R; Arata V; Silvestri S; Chiecchio A; Mozzati M
    J Oral Maxillofac Surg; 2011 Feb; 69(2):456-62. PubMed ID: 21129835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
    Chandra PA; Chandra AB; Todd GK
    Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
    Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
    J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors relating to the outcome of endodontic microsurgery.
    Lui JN; Khin MM; Krishnaswamy G; Chen NN
    J Endod; 2014 Aug; 40(8):1071-6. PubMed ID: 25069910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A once-yearly IV bisphosphonate for osteoporosis.
    Obstet Gynecol; 2008 May; 111(5):1208-9. PubMed ID: 18448761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.